ruxolitinib
Drug Details
- Generic Name
- ruxolitinib
- Brand Names
- JAKAFI, OPZELURA
- Application Number
- NDA202192
- Sponsor
- Catalent Pharma Solutions, LLC
- NDC Codes
- 11
- Dosage Forms
- TABLET, CREAM
- Routes
- ORAL, TOPICAL
- Active Ingredients
- RUXOLITINIB, RUXOLITINIB PHOSPHATE
Indications and Usage
1 INDICATIONS AND USAGE LEQSELVI™ is indicated for the treatment of adult patients with severe alopecia areata. Limitations of Use LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants. LEQSELVI is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with severe alopecia areata. ( 1 ) Limitations of Use: LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants. ( 1 )